Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks (Q42241391)
Jump to navigation
Jump to search
scientific article published on 26 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks |
scientific article published on 26 January 2014 |
Statements
1 reference
Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks (English)
1 reference
M Bloch
D Baker
F J Lee
R Richardson
A Carr
TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team
26 January 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference